Cargando…

Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial

BACKGROUND: This is a subgroup analysis of Korean patients from a phase 3 clinical trial investigating the efficacy and safety of ipragliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin. METHODS: This multicenter, placebo-controlled, double-blind, parallel-grou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Min, Kyung-Wan, Ku, Bon Jeong, Lee, Ji-Hyun, Kim, Min-Seon, Ahn, Kyu-Jeung, Lee, Moon-Kyu, Kokubo, Satoshi, Yoshida, Satoshi, Cho, Hyun-Ji, Cha, Bong-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409005/ https://www.ncbi.nlm.nih.gov/pubmed/28447440 http://dx.doi.org/10.4093/dmj.2017.41.2.135

Ejemplares similares

Efficacy, safety, and tolerability of ipragliflozin in Asian patients with type 2 diabetes mellitus and inadequate glycemic control with metformin: Results of a phase 3 randomized, placebo‐controlled, double‐blind, multicenter trial
por: Lu, Chieh‐Hsiang, et al.
Publicado: (2015)

Efficacy and safety of ipragliflozin as an add‐on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial
por: Han, Kyung‐Ah, et al.
Publicado: (2018)

Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial
por: Han, Eugene, et al.
Publicado: (2020)

Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM
por: Nakamura, Ichiro, et al.
Publicado: (2021)

Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes stratified by body mass index: A subgroup analysis of five randomized clinical trials
por: Kashiwagi, Atsunori, et al.
Publicado: (2016)

Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM
por: Nakamura, Ichiro, et al.
Publicado: (2021)

Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM
por: Nakamura, Ichiro, et al.
Publicado: (2021)

Glycosuria medicated with ipragliflozin and nifedipine or ipragliflozin and candesartan: a case report
por: Okada, Shuichi, et al.
Publicado: (2014)

Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes
por: Chin, Sang Ouk, et al.
Publicado: (2020)

A 52‐week randomized controlled trial of ipragliflozin or sitagliptin in type 2 diabetes combined with metformin: The N‐ISM study
por: Kitazawa, Masaru, et al.
Publicado: (2021)

Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway
por: Lee, Ji-Yeon, et al.
Publicado: (2021)

Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3‐month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long‐term Use study
por: Tobe, Kazuyuki, et al.
Publicado: (2019)

Clinical Characteristics of Patients Responding to Once-Daily Basal Insulin Therapy in Korean Subjects with Type 2 Diabetes
por: Song, Sun Ok, et al.
Publicado: (2015)

Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort
por: Kim, Hae Jin, et al.
Publicado: (2018)

Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study
por: Kashiwagi, A, et al.
Publicado: (2015)

Incidence of pterygospinous and pterygoalar bridges in dried skulls of Koreans
por: Ryu, Sol-Ji, et al.
Publicado: (2016)

Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD
por: Takahashi, Hirokazu, et al.
Publicado: (2021)

Metformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statement
por: Hur, Kyu Yeon, et al.
Publicado: (2020)

Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
por: Hur, Kyu Yeon, et al.
Publicado: (2020)

Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review
por: Ahn, Hyun Kyu, et al.
Publicado: (2020)

Novel ERBB Receptor Feedback Inhibitor 1 (ERRFI1) + 808 T/G Polymorphism Confers Protective Effect on Diabetic Nephropathy in a Korean Population
por: Lee, Ihn Suk, et al.
Publicado: (2013)

Safety of Ipragliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical Trials
por: Kashiwagi, Atsunori, et al.
Publicado: (2019)

Germline pathogenic variants in unselected Korean men with prostate cancer
por: So, Min-Kyung, et al.
Publicado: (2022)

Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study
por: Yoon, Kun Ho, et al.
Publicado: (2011)

Additional Effect of Dietary Fiber in Patients with Type 2 Diabetes Mellitus Using Metformin and Sulfonylurea: An Open-Label, Pilot Trial
por: Lee, Seung-Eun, et al.
Publicado: (2019)

Comparative Pharmacokinetics and Pharmacodynamics of a Novel Sodium-Glucose Cotransporter 2 Inhibitor, DWP16001, with Dapagliflozin and Ipragliflozin
por: Choi, Min-Koo, et al.
Publicado: (2020)

Attitudes of Korean and Chinese traditional medical doctors on education of East Asian traditional medicine
por: Lee, Hyun-Ji, et al.
Publicado: (2016)

Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease
por: Miyake, Teruki, et al.
Publicado: (2018)

The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes
por: Chung, Hyun Hee, et al.
Publicado: (2013)

Microarray Analysis of Papillary Thyroid Cancers in Korean
por: Kim, Hyun Sook, et al.
Publicado: (2010)

Effects of ambient temperature and dietary glycerol addition on growth performance, blood parameters and immune cell populations of Korean cattle steers
por: Kang, Hyeok Joong, et al.
Publicado: (2017)

Randomized, placebo‐controlled, double‐blind glycemic control trial of novel sodium‐dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus
por: Kashiwagi, Atsunori, et al.
Publicado: (2013)

Practical strategy for optimizing the timing of anti-tumor necrosis factor-α therapy in Crohn disease: A nationwide population-based study
por: Kwak, Min Seob, et al.
Publicado: (2020)

Bone Mineral Density in Prediabetic Men (Korean Diabetes J 2010;34:294-302)
por: Lee, Ju Hee, et al.
Publicado: (2010)

Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study
por: Koshizaka, Masaya, et al.
Publicado: (2020)

Ipragliflozin/tozinameran: Diabetic ketoacidosis: 2 case reports
Publicado: (2022)

Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients
por: Choi, Rihwa, et al.
Publicado: (2018)

Development of a Modified Korean Version of the Epworth Sleepiness Scale Reflecting Korean Sociocultural Lifestyle
por: Jung, Seo-Yeon, et al.
Publicado: (2018)

Effect of Adenotonsillectomy on Attention in Korean Children With Sleep-Disordered Breathing
por: Kim, Min Jae, et al.
Publicado: (2018)

Comparing greenhouse gas emissions and nutritional values based on Korean suggested meal plans and modified vegan meal plans
por: Park, Geun-woo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jrg3hap630cffiksdpa84np931